CD8+ cytotoxic T lymphocytes (CTL) and CD4+ T cells are the effector tumor infiltrating lymphocytes (TILs) observed in resected cancer tissue and are believed to participate in the host immune response against cancer which is considered a positive prognostic marker (149). The gene discussed is CD8A; the disease is neoplasm.